SAMENTHA GILLES: Open Payments
NPI 1063281624 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $101 |
| Axsome Therapeutics, Inc. | 1 | $36 |
| JAZZ PHARMACEUTICALS INC. | 2 | $30 |
| ABBVIE INC. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: BREZTRI, Sunosi, XYWAV, UBRELVY, FARXIGA, GIVLAARI, GARDASIL 9, MOUNJARO.
Industry payments across CT — which companies pay providers there.
